AI unlocks screening potential of body CT exams

Artificial intelligence (AI)-based assessment of body composition biomarkers...Read more on AuntMinnie.comRelated Reading: From lab to clinic: How AI can help AI enables screening of fracture risk from CT scans AI spots heart disease on CT lung screening exams AI accurately detects vertebral fractures on CT Can AI screen for nonalcoholic fatty liver disease?
Source: AuntMinnie.com Headlines - Category: Radiology Source Type: news

Related Links:

ConclusionUltrasonographically acquired HRI has a significant predictive impact on the detection of prediabetes and diabetes in patients with NAFLD.
Source: Indian Journal of Gastroenterology - Category: Gastroenterology Source Type: research
CHD is reported to be the primary cause of death in patients with NAFLD. Genetic susceptibility genes contribute to the developmental risk of NAFLD or CHD. Whether the genetic factors could affect the risk of ...
Source: Lipids in Health and Disease - Category: Lipidology Authors: Tags: Research Source Type: research
Conclusions: High-grade NAFLD is more present in symptomatic CHD. The higher degree of liver stiffness in patients with NAFLD, the higher risk of CHD in these NAFLD patients.
Source: Journal of Clinical Gastroenterology - Category: Gastroenterology Tags: LIVER, PANCREAS & BILIARY TRACT: Original Articles Source Type: research
This article addresses the pitfalls of the standard panel of liver function tests, discusses other non-invasive biomarkers and reviews imaging technologies which may revolutionise community-based diagnosis and stratification of chronic liver disease. PMID: 32097065 [PubMed - as supplied by publisher]
Source: British Journal of Hospital Medicine - Category: Internal Medicine Authors: Tags: Br J Hosp Med (Lond) Source Type: research
Scientists from 22 institutions, including UCLA, are recommending early diagnosis, prevention and treatment of severe chronic inflammation to reduce the risk of chronic disease and death worldwide.The group of international experts, which also includes scientists from the National Institutes of Health, Stanford University, Harvard Medical School, Columbia University Medical Center and University College London, point to inflammation-related diseases as the cause of 50 percent of all deaths worldwide.Inflammation is a naturally occurring response by the body ’s immune system that helps fight illness and infection. Whe...
Source: UCLA Newsroom: Health Sciences - Category: Universities & Medical Training Source Type: news
Authors: Mari A, Khoury T, Said Ahmad H, Abu Baker F, Kadah A, Sbeit W, Pellicano R, Mahamid M Abstract BACKGROUND: Non-alcoholic fatty liver (NAFLD) disease has become the commonest cause of end-stage liver disease. Patients with NAFLD have an increased risk of associated extrahepatic conditions, including structural and functional cardiovascular disease. Still, it is unknown if there is an association between NAFLD and valvular heart disease (VHD). OBJECTIVE: to determine the association between NAFLD and VHD. METHODS: We performed a single center retrospective study in EMMS Nazareth Hospital from April 2...
Source: Minerva Cardioangiologica - Category: Cardiology Tags: Minerva Cardioangiol Source Type: research
This study explored the proportion of NAFLD cases and increased liver fibrosis (LF), and the association between LF and either chronic kidney disease (CKD) or cardiovascular complications in T2DM patients. METHODS: - The study included 137 patients with non-insulin-treated T2DM and no known liver disease consecutively attending our diabetes outpatients service who underwent liver ultrasonography and liver stiffness measurement (LSM) using vibration-controlled transient elastography (FibroScan®). RESULTS: - The proportion of patients with hepatic steatosis on ultrasonography was 73.7%, and the proportion with ...
Source: Diabetes and Metabolism - Category: Endocrinology Authors: Tags: Diabetes Metab Source Type: research
Previous study reported that patients who suffered coronary heart disease (CHD) complicated with non-alcoholic fatty liver disease (NAFLD) had worse cardiac function and clinical outcomes than patients with CH...
Source: BMC Genomics - Category: Genetics & Stem Cells Authors: Tags: Research article Source Type: research
Parikh et al. conducted a cross-sectional study on the relationship of nonalcoholic fatty liver disease with advanced fibrosis (NAFLD-fibrosis) with stroke, heart disease, and major cardiovascular disease [1]. As indicators of NAFLD-fibrosis, the Fibrosis-4 Score (FIB-4) and NAFLD Fibrosis Score (NFS) were used for the analysis. Adjusted odds ratio (OR) (95% confidence interval [CI]) of the FIB-4 for stroke was 1.87 (1.00 –3.50). In addition, adjusted ORs of NAFLD-fibrosis for heart disease and major cardiovascular disease significantly increased.
Source: Journal of the Neurological Sciences - Category: Neurology Authors: Tags: Letter to the Editor Source Type: research
There is an increasing appreciation of the cardiovascular implications of nonalcoholic fatty liver disease with advanced fibrosis (NAFLD-fibrosis). However, data regarding stroke risk are limited. We sought to investigate whether NAFLD-fibrosis is associated with stroke in addition to heart disease.
Source: Journal of the Neurological Sciences - Category: Neurology Authors: Source Type: research
More News: Cardiology | CT Scan | Fatty Liver Disease (FLD) | Heart | Heart Disease | Heart Transplant | Liver | Liver Disease | Liver Transplant | Lung Transplant | Non-alcoholic Fatty Liver Diseases (NAFLD) | Orthopaedics | PET Scan | Radiology | Urology & Nephrology